Trial intelligence / Profile preview

Mucinex® in Stable Chronic Bronchitis

NCT05843669Phase 4Completed

Sponsor
American Health Research
Start
Jul 2023
Primary completion
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of guaifenesin in chronic bronchitis (CB), sponsored by American Health Research. Started Jul 2023; status: completed.

02

Drugs

guaifenesin
03

Conditions

chronic bronchitis (CB)

Beyond the preview

Go deeper on NCT05843669.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05843669.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call